Neuropeptide deficits in schizophrenia vs. Alzheimer's disease cerebral cortex.

Alterations in GABA-related transcriptome in the dorsolateral prefrontal cortex of subjects with schizophrenia. Mol Psychiatry (2007) 2.91

Bipolar disorder type 1 and schizophrenia are accompanied by decreased density of parvalbumin- and somatostatin-positive interneurons in the parahippocampal region. Acta Neuropathol (2011) 1.00

Putative psychosis genes in the prefrontal cortex: combined analysis of gene expression microarrays. BMC Psychiatry (2008) 1.00

Synapse-specific contributions in the cortical pathology of schizophrenia. Neurobiol Dis (2013) 0.91

NPY mRNA expression in the prefrontal cortex: Selective reduction in the superficial white matter of subjects with schizoaffective disorder. Schizophr Res (2009) 0.88

Marked decrease of neuropeptide Y Y2 receptor binding sites in the hippocampus in murine prion disease. Proc Natl Acad Sci U S A (1997) 0.85

Schizophrenia pathophysiology: are we any closer to a complete model? Ann Gen Psychiatry (2009) 0.83

Markedly Lower Glutamic Acid Decarboxylase 67 Protein Levels in a Subset of Boutons in Schizophrenia. Biol Psychiatry (2015) 0.80

Neuropeptide deficits in schizophrenia vs. Alzheimer's disease cerebral cortex. Biol Psychiatry (1996) 0.75

A new rating scale for Alzheimer's disease. Am J Psychiatry (1984) 15.16

Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer. N Engl J Med (1996) 11.72

Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia. Proc Natl Acad Sci U S A (2001) 6.68

Correlation between elevated levels of amyloid beta-peptide in the brain and cognitive decline. JAMA (2000) 6.55

Dopamine in schizophrenia: a review and reconceptualization. Am J Psychiatry (1991) 5.36

Pneumocystis carinii pneumonia in the United States. Epidemiologic, diagnostic, and clinical features. Ann Intern Med (1974) 4.10

Intraneuronal Abeta42 accumulation in human brain. Am J Pathol (2000) 3.83

Neuropathological evidence of graft survival and striatal reinnervation after the transplantation of fetal mesencephalic tissue in a patient with Parkinson's disease. N Engl J Med (1995) 3.64

Tangle and neuron numbers, but not amyloid load, predict cognitive status in Alzheimer's disease. Neurology (2003) 3.62

CNTNAP2 gene dosage variation is associated with schizophrenia and epilepsy. Mol Psychiatry (2007) 3.44

The interaction of mycoplasmas with mammalian cells. I. HeLa cells, neutrophils, and eosinophils. J Exp Med (1966) 3.38

Cholinergic markers in elderly patients with early signs of Alzheimer disease. JAMA (1999) 3.22

Regional distribution of neuritic plaques in the nondemented elderly and subjects with very mild Alzheimer disease. Arch Neurol (1998) 3.20

Coping skills training for youth with diabetes mellitus has long-lasting effects on metabolic control and quality of life. J Pediatr (2000) 3.02

Defects in mitochondrial protein synthesis and respiratory chain activity segregate with the tRNA(Leu(UUR)) mutation associated with mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes. Mol Cell Biol (1992) 2.83

A neuronal morphologic type unique to humans and great apes. Proc Natl Acad Sci U S A (1999) 2.81

A randomized controlled trial of prednisone in Alzheimer's disease. Alzheimer's Disease Cooperative Study. Neurology (2000) 2.76

National Institute of Mental Health Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE): Alzheimer disease trial methodology. Am J Geriatr Psychiatry (2001) 2.74

Acid sphingomyelinase deficient mice: a model of types A and B Niemann-Pick disease. Nat Genet (1995) 2.66

Evidence for a susceptibility gene for autism on chromosome 2 and for genetic heterogeneity. Am J Hum Genet (2001) 2.51

Alzheimer's disease: X-ray spectrometric evidence of aluminum accumulation in neurofibrillary tangle-bearing neurons. Science (1980) 2.45

A longitudinal study of Alzheimer's disease: measurement, rate, and predictors of cognitive deterioration. Am J Psychiatry (1994) 2.41

Bacteriologic diagnosis of acute pneumonia. Comparison of sputum, transtracheal aspirates, and lung aspirates. JAMA (1976) 2.39

Studies of PPLO infection. II. The neurotoxin of Mycoplasma neurolyticum. J Exp Med (1966) 2.34

Efficacy of dexmedetomidine compared with midazolam for sedation in adult intensive care patients: a systematic review. Br J Anaesth (2013) 2.17

Studies of PPLO infection. I. The production of cerebral polyarteritis by Mycoplasma gallisepticum in turkeys; the neurotoxic property of the Mycoplasma. J Exp Med (1966) 2.13

The evolution of diagnosis in early Parkinson disease. Parkinson Study Group. Arch Neurol (2000) 2.08

The pathology of Legionnaires' disease. Fourteen fatal cases from the 1977 outbreak in Vermont. Arch Pathol Lab Med (1978) 2.06

Rising mortality from motoneuron disease in the USA, 1962-84. Lancet (1989) 2.05

Neurofibrillary tangles in nondemented elderly subjects and mild Alzheimer disease. Arch Neurol (1999) 2.02

Guidelines for the identification, evaluation, and management of systemic hypertension in dogs and cats. J Vet Intern Med (2007) 1.95

Ionotropic glutamate receptor binding and subunit mRNA expression in thalamic nuclei in schizophrenia. Am J Psychiatry (2000) 1.93

Distribution, propagation, and coordination of contractile activity in lymphatics. Am J Physiol (1993) 1.92

Coronary artery disease is associated with Alzheimer disease neuropathology in APOE4 carriers. Neurology (2006) 1.89

Evidence of neuronal oxidative damage in Alzheimer's disease. Am J Pathol (1996) 1.87

Patterns of risk in first-degree relatives of patients with Alzheimer's disease. Arch Gen Psychiatry (1994) 1.84

The Alzheimer's disease assessment scale: an instrument for assessing treatment efficacy. Psychopharmacol Bull (1983) 1.81

Reliability of the family history method in genetic studies of Alzheimer's disease and related dementias. Am J Psychiatry (1986) 1.80

Serotonergic studies in patients with affective and personality disorders. Correlates with suicidal and impulsive aggressive behavior. Arch Gen Psychiatry (1989) 1.79

Less Alzheimer disease neuropathology in medicated hypertensive than nonhypertensive persons. Neurology (2009) 1.78

A psychobiological perspective on the personality disorders. Am J Psychiatry (1991) 1.76

Protocadherins: a large family of cadherin-related molecules in central nervous system. EMBO J (1993) 1.72

The iritable colon of childhood (chronic nonspecific diarrhea syndrome). J Pediatr (1966) 1.70

Effect of combined risedronate and hormone replacement therapies on bone mineral density in postmenopausal women. J Clin Endocrinol Metab (2001) 1.70

Efficacy and safety of lovastatin in adolescent males with heterozygous familial hypercholesterolemia: a randomized controlled trial. JAMA (1999) 1.70

Ventricular enlargement in poor-outcome schizophrenia. Biol Psychiatry (1998) 1.70

Diabetes mellitus in midlife and the risk of dementia three decades later. Neurology (2004) 1.70

Neocortical neurofibrillary tangles correlate with dementia severity in Alzheimer's disease. Arch Neurol (1995) 1.69

Dissociation of neuropathology from severity of dementia in late-onset Alzheimer disease. Neurology (2006) 1.68

Cyclophosphamide and cisplatin versus paclitaxel and cisplatin: a phase III randomized trial in patients with suboptimal stage III/IV ovarian cancer (from the Gynecologic Oncology Group). Semin Oncol (1996) 1.66

Psychosocial predictors of failure to return to work in non-chronic non-specific low back pain: a systematic review. Occup Environ Med (2008) 1.64

Short-term effects of coping skills training as adjunct to intensive therapy in adolescents. Diabetes Care (1998) 1.63

Intraneuronal aluminum accumulation in amyotrophic lateral sclerosis and Parkinsonism-dementia of Guam. Science (1982) 1.63

Neuropeptide abnormalities in patients with early Alzheimer disease. Arch Gen Psychiatry (1999) 1.62

Changes in NMDA receptor subunits and interacting PSD proteins in dorsolateral prefrontal and anterior cingulate cortex indicate abnormal regional expression in schizophrenia. Mol Psychiatry (2006) 1.62

Guanfacine treatment of cognitive impairment in schizophrenia. Neuropsychopharmacology (2001) 1.61

Symptoms, cognitive functioning, and adaptive skills in geriatric patients with lifelong schizophrenia: a comparison across treatment sites. Am J Psychiatry (1998) 1.60

Manganese intoxication in the rhesus monkey: a clinical, imaging, pathologic, and biochemical study. Neurology (1996) 1.60

Alendronate and estrogen effects in postmenopausal women with low bone mineral density. Alendronate/Estrogen Study Group. J Clin Endocrinol Metab (2000) 1.58

The interaction of mycoplasmas with mammalian cells. II. Monocytes and lymphocytes. J Exp Med (1966) 1.57

Cognitive performance of male adolescents is lower than controls across psychiatric disorders: a population-based study. Acta Psychiatr Scand (2004) 1.57

Two decades of increasing mortality from Parkinson's disease among the US elderly. Arch Neurol (1990) 1.56

Association between nonpsychotic psychiatric diagnoses in adolescent males and subsequent onset of schizophrenia. Arch Gen Psychiatry (2001) 1.55

Investigation of a fatality from nonoccupational aluminum phosphide exposure: measurement of aluminum in tissue and body fluids as a marker of exposure. J Lab Clin Med (1993) 1.53

Myxoedema preceding hyperthyroidism. Lancet (1971) 1.52

Feeding studies in low-birth-weight infants. I. Relationships of dietary protein, fat, and electrolyte to rates of weight gain, clinical courses, and serum chemical concentrations. J Pediatr (1967) 1.52

Eye tracking impairment in clinically identified patients with schizotypal personality disorder. Am J Psychiatry (1990) 1.51

Eye tracking, attention, and schizotypal symptoms in nonpsychotic relatives of patients with schizophrenia. Arch Gen Psychiatry (1997) 1.51

Neurological manifestations of hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber disease): report of 2 cases and review of the literature. Ann Neurol (1978) 1.50

Accumulation of phosphorylated neurofilaments in anterior horn motoneurons of amyotrophic lateral sclerosis patients. J Neuropathol Exp Neurol (1988) 1.49

The longitudinal stability of cognitive impairment in schizophrenia. Mini-mental state scores at one- and two-year follow-ups in geriatric in-patients. Br J Psychiatry (1995) 1.46

Clinical and psychosocial factors associated with achievement of treatment goals in adolescents with diabetes mellitus. J Adolesc Health (2001) 1.46

Metabolic and clinical effects of glibenclamide. Lancet (1970) 1.46

Protein nitration in Parkinson's disease. J Neuropathol Exp Neurol (1998) 1.45

Deterioration on the Blessed test in Alzheimer's disease: longitudinal data and their implications for clinical trials and identification of subtypes. Psychiatry Res (1992) 1.45

Six-year follow-up study of cognitive and functional status across the lifespan in schizophrenia: a comparison with Alzheimer's disease and normal aging. Am J Psychiatry (2001) 1.43

Neurochemical correlates of dementia severity in Alzheimer's disease: relative importance of the cholinergic deficits. J Neurochem (1995) 1.41